Program Guide – ASCO Meeting Program Guide
Caitlin McIntyre , Vasilisa Rudneva , Allison Richards , Wungki Park , William Jarnagin , Mark Donoghue , Eileen O’Reilly UT Health San Antonio, Memorial Sloan Kettering Cancer Center Background: The genomics of pancreatic ductal adenocarcinoma (PDAC) have been increasingly understood allowing for improvements in treatment, yet the clinical relevance of PDAC evolution is less well studied. The aim of this study is to evaluate genomic differences and clinical correlations between primary pancreatic tumors
